Alpha-1 Antitrypsin Deficiency Clinical Trial Patient Recruitment

Alpha-1 antitrypsin deficiency patient recruitment for augmentation therapy and gene therapy clinical trials.

Who qualifies: Adults with confirmed AATD (ZZ, SZ, or null genotype) with or without lung or liver disease.

Recruitment challenges: Genotype confirmation and AAT serum level requirements.

Our approach: Pulmonology and hepatology referral networks, Alpha-1 Foundation patient registry access.